Improving How We Understand Side Effects in Breast Cancer Treatment
Analyzing Patient-Level Data in a Breast Cancer Clinical Trial
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-11121029
This work aims to better understand and manage treatment side effects for women with breast cancer by using information reported directly by patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-11121029 on ClinicalTrials.gov |
What this research studies
Many women receiving breast cancer treatment experience side effects that can impact their daily lives, but these are often not fully captured in traditional reports. We know that patients and their healthcare providers don't always connect symptoms directly to the treatment, leading to underreporting of important side effects like fatigue or neuropathy. This project focuses on finding new ways to analyze patient-reported information about side effects in real-time. Our goal is to present this data to doctors in a clear way, so they can act quickly to help manage side effects and improve patient well-being.
Who could benefit from this research
Good fit: This work is relevant to patients who have participated in breast cancer clinical trials, especially those where patient-reported side effect data was collected.
Not a fit: Patients not undergoing breast cancer treatment or not participating in clinical trials where patient-reported outcomes are collected would not directly benefit from this specific data analysis.
Why it matters
Potential benefit: If successful, this work could lead to earlier recognition and better management of treatment side effects, improving the quality of life for women undergoing breast cancer therapy.
How similar studies have performed: While patient-reported outcome platforms exist and have shown promise in collecting data, this project addresses the novel challenge of analyzing and utilizing this patient-level toxicity data in real-time for clinical decision-making.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SOMANI, AMRITA BASU — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: SOMANI, AMRITA BASU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer, Breast Cancer therapy